Emphasis on Icosapent Ethyl for Cardiovascular Risk Reduction: A Systematic Review.

Sutariya, Bansi; Montenegro, Diana M; Chukwu, Michael; Ehsan, Paghunda; Aburumman, Rawia N; Muthanna, Shivani Ishwarya; Menon, Swathi Radhakrishnan; Vithani, Vruti; Penumetcha, Sai Sri

Sutariya, Bansi; Montenegro, Diana M; Chukwu, Michael; Ehsan, Paghunda; Aburumman, Rawia N; Muthanna, Shivani Ishwarya; Menon, Swathi Radhakrishnan; Vithani, Vruti; Penumetcha, Sai Sri.

Afiliação

Sutariya B; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Montenegro DM; General Medicine, Government Medical College, Surat, IND.
Chukwu M; General Surgery, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Ehsan P; General Surgery, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Aburumman RN; General Surgery, Pilgrim Hospital, Boston, GBR.
Muthanna SI; Research, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Menon SR; Internal Medicine, Hayatabad Medical Complex Peshawar, Peshawar, PAK.
Vithani V; Internal Medicine, California Institute of Behavioral Neurosciences & Psychology, Fairfield, USA.
Penumetcha SS; Internal Medicine, Mu'tah University, Amman, JOR.

Cureus ; 14(12): e32346, 2022 Dec.

Article em En | MEDLINE | ID: mdl-36632258

Palavras-chave

cardiovascular risk reduction; coronary artery disease; eicosapentaenoic acid (epa); icosapent ethyl; vascepa

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies / Systematic_reviews Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google